|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 14/705 | (2006.01) |
| C12N 15/12 | (2006.01) | ||
| A61K 31/7088 | (2006.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3394093 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16826843.1 |
| Date of filing the European patent application | 2016-12-23 | |
| (97) | Date of publication of the European application | 2018-10-31 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-26 |
| (46) | Date of publication of the claims translation | 2022-04-25 |
| (86) | Number | PCT/US2016/068552 |
| Date | 2016-12-23 |
| (87) | Number | WO 2017/112943 |
| Date | 2017-06-29 |
| (30) | Number | Date | Country code |
| 201562387168 P | 2015-12-23 | US | |
| 201662290413 P | 2016-02-02 | US |
| (72) |
FREDERICK, Joshua , US
BAI, Ailin , US
|
| (73) |
ModernaTX, Inc. ,
200 Technology Square, Cambridge, MA 02139,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | OX40 ligandus koduojančių polinukleotidų naudojimo būdai |
| METHODS OF USING OX40 LIGAND ENCODING POLYNUCLEOTIDES |
| Payment date | Validity (years) | Amount | |
| 2023-12-01 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-12-23 |